tirzepatide launch FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes New Weight Loss Drug May

Patients switching between compounding providers receive different formulations with different inactive ingredients affecting stability, different preparation methods affecting sterility, and different quality control standards affecting what ends up in each dose

On June 16, 2026, researchers led by Dr

13 Workout Supplements that Work: From Creatine to BCAAs Meet your new gym buddies! These 13 workout supplements can help you crush those fitness goalswhether you are aiming to increase muscle mass, build endurance, or power through your workouts with more energy

I train twice a day." Grillo is also a proponent for the use of peptides, which are perfromance enhancing compounds and recovery agents consisting of two or more amino acids linked in a chain

47 Richy, F., Schacht, E., Bruyere, O., Ethgen, O., Gourlay, M., and Reginster, J